DENGUE
Clinical trials for DENGUE explained in plain language.
Never miss a new study
Get alerted when new DENGUE trials appear
Sign up with your email to follow new studies for DENGUE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a common arthritis drug tame deadly dengue inflammation?
Disease control OngoingThis study tests whether anakinra, a drug that reduces inflammation, can help people with severe dengue who have dangerously high levels of inflammation. About 160 hospitalized patients will receive either anakinra or a placebo. The goal is to see if the drug can prevent organ fa…
Matched conditions: DENGUE
Phase: PHASE2 • Sponsor: Oxford University Clinical Research Unit, Vietnam • Aim: Disease control
Last updated May 19, 2026 11:53 UTC
-
Dengue vaccine study seeks clues in immune cells
Knowledge-focused OngoingThis study will give the Takeda dengue vaccine to 30 healthy adults aged 18-65 to learn how their T-cells (a type of immune cell) respond. The goal is to find markers that show whether the vaccine protects against all four types of dengue virus. This is a research study, not a tr…
Matched conditions: DENGUE
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 26, 2026 04:09 UTC
-
Where do people go? new study maps movement to stop dengue
Knowledge-focused OngoingThis study aims to improve how we predict and prevent dengue outbreaks by looking at how people move around the city of Cienfuegos, Cuba. Researchers will combine travel data, environmental risks, and past outbreak information to build better computer models. About 810 residents …
Matched conditions: DENGUE
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated May 26, 2026 04:08 UTC
-
800,000 dengue vaccine recipients analyzed in massive vietnam study
Knowledge-focused OngoingThis study reviews existing records from 800,000 people who received the TAK-003 (Qdenga) dengue vaccine at VNVC centers in Vietnam. Researchers will describe the age, sex, health history, and vaccination patterns of these individuals. No new treatments or direct contact with par…
Matched conditions: DENGUE
Sponsor: Tam Anh Research Institute • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC